Medical researchers report on their identification of high-risk patients with stage 3A disease and microscopic lymph node metastases who would benefit from adjuvant therapy. The use of additional ...
TAMPA, Fla. – The use of additional adjuvant therapy beyond initial treatment has greatly improved outcomes and reduced the risk of disease recurrence for high-risk patients with melanoma. While there ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback